✦ LIBER ✦

Discovery and characterization of taspoglutide, a novel analogue of human glucagon-like peptide-1, engineered for sustained therapeutic activity in type 2 diabetes

✍ Scribed by J. Z. Dong; Y. Shen; J. Zhang; N. Tsomaia; D. F. Mierke; J. E. Taylor

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Taspoglutide, a novel human once-weekly

✍ E. Sebokova; A. Bénardeau; U. Sprecher; S. Sewing; L. Tobalina; C. Migliorini 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 597 KB

Liraglutide, a once-daily human glucagon

✍ A. Garber; R. R. Henry; R. Ratner; P. Hale; C. T. Chang; B. Bode 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 971 KB

A 5-week study of the pharmacokinetics a

✍ P. Barrington; J. Y. Chien; H. D. H. Showalter; K. Schneck; S. Cui; F. Tibaldi; 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 647 KB

Weight loss with liraglutide, a once-dai

✍ J. Jendle; M. A. Nauck; D. R. Matthews; A. Frid; K. Hermansen; M. Düring; M. Zdr 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 579 KB

The effects of LY2189265, a long-acting

✍ G. E. Umpierrez; T. Blevins; J. Rosenstock; C. Cheng; J. H. Anderson; E. J. Bast 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 652 KB